This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Suzhou Botany Biomedical Co., Ltd.. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 121 
1 out of 1 Years Active: 2017-2022
Title: Innovations and Contributions of Inventor Honglin Wang
Introduction
Honglin Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, Wang's work focuses on compounds that have potential therapeutic applications.
Latest Patents
One of his latest patents is titled "Crystal of tricyclic compound." This invention relates to a specific crystal of a tricyclic compound, particularly (S)-8-(4,4-difluorocyclohexyl)-8H-thieno[3,4]pyrrolo[1,5-a]imidazole. The patent details a preparation method, a crystal composition, and a pharmaceutical composition, highlighting the crystal's excellent physical properties, high safety, and metabolic stability. It also demonstrates a good inhibitory effect on IDO, showcasing its high medicinal value.
Another significant patent by Wang is for a "Pentacyclic triterpenoid compound with modified structure and preparation method and use thereof." This invention introduces new pentacyclic triterpenes that can effectively treat psoriasis and selectively inhibit the in vitro differentiation of T1 and T17 cells. This innovation has the potential to be used in treating T1- or T17-mediated autoimmune diseases.
Career Highlights
Honglin Wang has worked with prominent companies in the pharmaceutical industry, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Suzhou Botany Biomedical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Wang has collaborated with notable colleagues such as Shilan Liu and Dahai Wang. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations in the pharmaceutical field.
Conclusion
In summary, Honglin Wang is a distinguished inventor whose work in pharmaceutical innovations has the potential to significantly impact the treatment of various diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile